Bluebird Bio Inc (BLUE)

Jun 05, 2025

bluebird bio, Inc. (BLUE) Nears Acquisition by Carlyle and SK Capital - MSN

Jun 05, 2025

Jun 04, 2025

Beta-Thalassemia (B-thal) Market Set to Witness - openPR.com

Jun 04, 2025

Jun 04, 2025

Sickle Cell Treatment Market 2025 | Advances, Drugs, Therapies & - openPR.com

Jun 04, 2025

Jun 03, 2025

bluebird bio acquired to scale gene therapy access By Investing.com - Investing.com Canada

Jun 03, 2025

Jun 02, 2025

Carlyle, SK Capital close deal for bluebird bio, injecting capital for commercial expansion - The Business Journals

Jun 02, 2025

Jun 02, 2025

Carlyle, SK Capital Partners Close Bluebird Bio Acquisition - marketscreener.com

Jun 02, 2025

Jun 02, 2025

Bluebird Bio Announces Completion Of Acquisition By Carlyle And SK Capital - marketscreener.com

Jun 02, 2025

Jun 02, 2025

Bluebird Bio (BLUE) Acquired by Carlyle and SK Capital Partners | BLUE Stock News - GuruFocus

Jun 02, 2025

Jun 02, 2025

bluebird bio Announces Completion of Acquisition by Carlyle and SK Capital | BLUE Stock News - GuruFocus

Jun 02, 2025

Jun 02, 2025

bluebird bio Announces Completion of Acquisition by Carlyle and SK Capital - Business Wire

Jun 02, 2025

May 31, 2025

Carlyle, SK Capital Partners disclose expected closing date of bluebird bio deal - MSN

May 31, 2025

May 31, 2025

Carlyle and SK Capital to acquire bluebird bio By Investing.com - Investing.com South Africa

May 31, 2025

May 31, 2025

Northern Trust Corp Reduces Holdings in bluebird bio, Inc. (NASDAQ:BLUE) - Defense World

May 31, 2025

May 30, 2025

Bluebird Bio (BLUE) Acquisition Nears Completion - GuruFocus

May 30, 2025

May 30, 2025

Carlyle, SK Capital, Beacon Set To Close Bluebird Bio Acquisition - Nasdaq

May 30, 2025

May 30, 2025

Carlyle and SK Capital Partners Announce Expiration of bluebird bio Tender Offer - marketscreener.com

May 30, 2025

May 30, 2025

Carlyle-Led Group Closes Tender Offer for Bluebird Bio - marketscreener.com

May 30, 2025

May 30, 2025

Carlyle and SK Capital to acquire bluebird bio - Investing.com

May 30, 2025

May 30, 2025

Carlyle and SK Capital Partners Announce Expiration of bluebird bio Tender Offer | BLUE Stock News - GuruFocus

May 30, 2025

May 27, 2025

Bluebird Bio Beats Investor Suit Over FDA Cancer Warning - Law360

May 27, 2025

May 27, 2025

Bluebird Bio’s SWOT analysis: biotech firm’s stock faces merger crossroads By Investing.com - Investing.com India

May 27, 2025

May 27, 2025

Bluebird Bio’s SWOT analysis: biotech firm’s stock faces merger crossroads - Investing.com

May 27, 2025

May 27, 2025

Gene Therapy Death Worsens Picture for an Already Troubled Field - Barron's

May 27, 2025

May 27, 2025

bluebird bio Reminds Stockholders to Act Now to Tender Shares fo - GuruFocus

May 27, 2025

May 27, 2025

bluebird bio Reminds Stockholders to Act Now to Tender Shares for Acquisition by Carlyle and SK Capital - BioSpace

May 27, 2025

May 27, 2025

Bluebird Beats Investor Lawsuit Over FDA Black Box Warning (1) - Bloomberg Law News

May 27, 2025

May 25, 2025

High Noon For bluebird (NASDAQ:BLUE) - Seeking Alpha

May 25, 2025

May 20, 2025

PepGen Appoints New CTO with Bluebird Bio Experience | BLUE Stoc - GuruFocus

May 20, 2025

May 20, 2025

PepGen Appoints New CTO with Bluebird Bio Experience | BLUE Stock News - GuruFocus

May 20, 2025

May 20, 2025

Analysts Set bluebird bio, Inc. (NASDAQ:BLUE) Price Target at $44.60 - Defense World

May 20, 2025

May 19, 2025

Bluebird Beats Patent Case Over Blood Disease Therapies - Law360

May 19, 2025

May 19, 2025

Bluebird Wins Patent Fight Over Two High-Priced Gene Therapies - Bloomberg Law News

May 19, 2025

May 18, 2025

Dimensional Fund Advisors LP Sells 592,968 Shares of bluebird bio, Inc. (NASDAQ:BLUE) - Defense World

May 18, 2025

May 17, 2025

Tower Research Capital LLC TRC Reduces Stock Position in bluebird bio, Inc. (NASDAQ:BLUE) - Defense World

May 17, 2025

May 16, 2025

Carlyle, SK Capital Partners and bluebird bio Provide Updated Tender Instructions - BioSpace

May 16, 2025

May 16, 2025

Carlyle, SK Capital Partners and bluebird bio Provide Updated Te - GuruFocus

May 16, 2025

May 16, 2025

Carlyle, SK Capital Partners And Bluebird Bio Provide Updated Tender Instructions - marketscreener.com

May 16, 2025

May 15, 2025

Bluebird Bio's Acquisition Deal Offers Shareholders New Cash Option - Finimize

May 15, 2025

May 15, 2025

Beta thalassemia Market: Epidemiology, Therapies, Companies, - openPR.com

May 15, 2025

May 15, 2025

Bluebird Bio (BLUE) Reports Q1 Loss, Lags Revenue Estimates - MSN

May 15, 2025

May 15, 2025

bluebird bio updates terms of Carlyle, SK Capital buyout By Investing.com - Investing.com Canada

May 15, 2025

May 15, 2025

Carlyle and SK Capital boost Bluebird Bio bid, offering flexible payout terms - Private Equity Insights

May 15, 2025

May 15, 2025

bluebird bio (NASDAQ:BLUE) Coverage Initiated by Analysts at StockNews.com - Defense World

May 15, 2025

May 15, 2025

Bluebird: Q1 Earnings Snapshot - New Haven Register

May 15, 2025

May 15, 2025

Carlyle Group, SK Capital secure all regulatory approvals to acquire bluebird bio - MSN

May 15, 2025